Literature DB >> 17429587

[Successful therapy of ulcerated necrobiosis lipoidica non diabeticorum with cyclosporine A].

E Aslan1, A Körber, S Grabbe, J Dissemond.   

Abstract

Necrobiosis lipoidica is an inflammatory granulomatous skin disease of unknown etiology which is associated with diabetes mellitus in about 60% of the patients. In 15-35% of the affected patients painful ulcerations may occur after minimal trauma which can be extremely refractory to therapy. Because of the unknown pathomechanisms, current therapeutic options are limited. We report on a 68-year-old patient with an 18 year history of ulcerated necrobiosis lipoidica non diabeticorum of both lower limbs, which responded to systemic cyclosporine A. Based on this case, we discuss the role of cyclosporine A in patients with necrobiosis lipoidica in the context of the disease etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429587     DOI: 10.1007/s00105-006-1282-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  17 in total

1.  Successful treatment of ulcerated necrobiosis lipoidica with mycophenolate mofetil.

Authors:  G Reinhard; F Lohmann; M Uerlich; R Bauer; T Bieber
Journal:  Acta Derm Venereol       Date:  2000 Jul-Aug       Impact factor: 4.437

2.  Clearance of necrobiosis lipoidica with fumaric acid esters.

Authors:  T Gambichler; A Kreuter; M Freitag; F M Pawlak; N H Brockmeyer; P Altmeyer
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

3.  Healing of severe ulcerative necrobiosis lipoidica with cyclosporin.

Authors:  Amy Stanway; Marius Rademaker; Paul Newman
Journal:  Australas J Dermatol       Date:  2004-05       Impact factor: 2.875

Review 4.  Update on the use of ciclosporin in immune-mediated dermatoses.

Authors:  C E M Griffiths; A Katsambas; B A C Dijkmans; A Y Finlay; V C Ho; A Johnston; T A Luger; U Mrowietz; K Thestrup-Pedersen
Journal:  Br J Dermatol       Date:  2006-07       Impact factor: 9.302

Review 5.  Necrobiosis lipoidica.

Authors:  M H Lowitt; J S Dover
Journal:  J Am Acad Dermatol       Date:  1991-11       Impact factor: 11.527

6.  [Not Available].

Authors:  G MIESCHER; M LEDER
Journal:  Dermatologica       Date:  1948

7.  Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin.

Authors:  A Darvay; K M Acland; R Russell-Jones
Journal:  Br J Dermatol       Date:  1999-10       Impact factor: 9.302

8.  Necrobiosis lipoidica: treatment with systemic corticosteroids.

Authors:  P Petzelbauer; K Wolff; G Tappeiner
Journal:  Br J Dermatol       Date:  1992-06       Impact factor: 9.302

Review 9.  Clinical management of pyoderma gangrenosum.

Authors:  Uwe Wollina
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

10.  Healing of necrobiotic ulcers with antiplatelet therapy. Correlation with plasma thromboxane levels.

Authors:  M C Heng; M K Song; M K Heng
Journal:  Int J Dermatol       Date:  1989-04       Impact factor: 2.736

View more
  6 in total

1.  Necrobiosis lipoidica diabeticorum.

Authors:  Andreas Körber; Joachim Dissemond
Journal:  CMAJ       Date:  2007-12-04       Impact factor: 8.262

2.  [Necrobiosis lipoidica. Variants on a theme].

Authors:  E Geissler; H Laaff; K Technau; L Bruckner-Tuderman; D Nashan
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

3.  Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten patients.

Authors:  Cindy Franklin; Maren Stoffels-Weindorf; Uwe Hillen; Joachim Dissemond
Journal:  Int Wound J       Date:  2013-10-07       Impact factor: 3.315

4.  [Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy].

Authors:  D Meyersburg; M P Schön; H P Bertsch; C S Seitz
Journal:  Hautarzt       Date:  2011-09       Impact factor: 0.751

5.  Miescher's granulomatosis (granulomatosis disciformis chronica et progressiva) in a non-diabetic patient--case report.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło; Iwona Rogala-Poborska
Journal:  Diagn Pathol       Date:  2009-08-28       Impact factor: 2.644

Review 6.  Treatment Modalities of Necrobiosis Lipoidica: A Concise Systematic Review.

Authors:  Amir Feily; Shadi Mehraban
Journal:  Dermatol Reports       Date:  2015-06-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.